XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Other financing activities (2023 - 2026)

Updated

XORTX Therapeutics (XRTX) posted Other financing activities of -$827,663 for the quarter ended Jun 30, 2026, compared with $91,477 a year earlier.

Analysis

XORTX Therapeutics (XRTX) Other financing activities (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Other financing activities at XORTX Therapeutics was -$1.18 million; for the year ended Dec 31, 2022, it was $14.87 million.

  • In prior years, XORTX Therapeutics' Other financing activities was $134,516 in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 XORTX Therapeutics 1.61 Mn -1.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -827,663.00
Mar 31, 2026 -81,968.00
Sep 30, 2025 -358,900.00
Jun 30, 2025 91,477.00
Mar 31, 2025 -22,849.00
Mar 31, 2024 -297,607.00
Mar 31, 2023 -6,210.00
API Access

XORTX Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=XRTX&period=max&api_key=YOUR_API_KEY